Agriculture & Biology
Lymphocytic choriomeningitis mammarenavirus
100%
antibody formation
58%
T-lymphocytes
54%
viruses
38%
genetically modified organisms
26%
cytotoxic T-lymphocytes
20%
B-lymphocytes
19%
mice
14%
receptors
10%
spleen
8%
immunopathology
7%
infection
7%
antigen presentation
7%
kinetics
6%
immunosuppression
5%
point mutation
5%
dosage
5%
transgenes
4%
macrophages
4%
monoclonal antibodies
4%
glycoproteins
4%
peptides
3%
mutants
2%
tissues
2%
Medicine & Life Sciences
Lymphocytic choriomeningitis virus
82%
Antibody Formation
53%
Antiviral Agents
50%
Viruses
39%
T-Lymphocytes
36%
Cytotoxic T-Lymphocytes
15%
B-Lymphocytes
15%
T-Cell Antigen Receptor
15%
Transgenic Mice
13%
peptide 32
8%
Spleen
7%
Kinetics
7%
Infections
7%
Adoptive Transfer
5%
Antigen Presentation
5%
Lymphoid Tissue
5%
Transgenes
4%
Point Mutation
4%
Immunosuppression
4%
Glycoproteins
4%
Monoclonal Antibodies
3%
Macrophages
3%
Therapeutics
0%